Aaron Walton

590 total citations
19 papers, 395 citations indexed

About

Aaron Walton is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Aaron Walton has authored 19 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Aaron Walton's work include Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (10 papers) and Infectious Diseases and Tuberculosis (3 papers). Aaron Walton is often cited by papers focused on Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (10 papers) and Infectious Diseases and Tuberculosis (3 papers). Aaron Walton collaborates with scholars based in Australia, United Kingdom and Israel. Aaron Walton's co-authors include N. Deborah Friedman, Eugene Athan, D. O’Brien, Anthony McDonald, Peter Callan, Mitchell J. Schwaber, Yehuda Carmeli, Andrew Hughes, Andrew Hughes and Ian Holten and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.

In The Last Decade

Aaron Walton

19 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron Walton Australia 10 295 164 153 103 71 19 395
Ayşe Yüce Türkiye 10 113 0.4× 60 0.4× 148 1.0× 40 0.4× 30 0.4× 29 302
Nicolynn C. Cole United States 11 90 0.3× 36 0.2× 76 0.5× 77 0.7× 153 2.2× 17 328
Sittana S. Elshafie Qatar 11 136 0.5× 46 0.3× 69 0.5× 17 0.2× 54 0.8× 25 321
Sydney Malama Zambia 11 162 0.5× 36 0.2× 204 1.3× 53 0.5× 39 0.5× 23 292
Anupop Jitmuang Thailand 12 217 0.7× 15 0.1× 145 0.9× 53 0.5× 128 1.8× 33 428
Claudio Castelberg Switzerland 6 220 0.7× 112 0.7× 169 1.1× 16 0.2× 122 1.7× 6 344
P. Gialanella United States 11 167 0.6× 30 0.2× 297 1.9× 24 0.2× 33 0.5× 12 406
Raman Sardana India 9 292 1.0× 20 0.1× 402 2.6× 32 0.3× 35 0.5× 34 553
Kaye Evans United States 6 145 0.5× 28 0.2× 211 1.4× 46 0.4× 32 0.5× 15 273
Pilar Marín‐Casanova Spain 9 238 0.8× 35 0.2× 123 0.8× 8 0.1× 95 1.3× 16 384

Countries citing papers authored by Aaron Walton

Since Specialization
Citations

This map shows the geographic impact of Aaron Walton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Walton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Walton more than expected).

Fields of papers citing papers by Aaron Walton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Walton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Walton. The network helps show where Aaron Walton may publish in the future.

Co-authorship network of co-authors of Aaron Walton

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Walton. A scholar is included among the top collaborators of Aaron Walton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Walton. Aaron Walton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Walton, Aaron, et al.. (2022). Aerococcus urinae, a rare cause of aortic root abscess: a case report. Journal of Medical Case Reports. 16(1). 1 indexed citations
2.
3.
Solter, Ester, Jason C. Kwong, Aaron Walton, et al.. (2020). A multi-institutional outbreak of New Delhi metallo-β-lactamase–producing Escherichia coli with subsequent acquisition of the Klebsiella pneumoniae carbapenemase gene. Infection Control and Hospital Epidemiology. 42(9). 1124–1127. 1 indexed citations
4.
O’Brien, D., N. Deborah Friedman, Aaron Walton, Andrew Hughes, & Eugene Athan. (2020). Risk Factors Associated with Antibiotic Treatment Failure of Buruli Ulcer. Antimicrobial Agents and Chemotherapy. 64(9). 8 indexed citations
5.
O’Brien, D., et al.. (2019). Six vs Eight Weeks of Antibiotics for Small Mycobacterium ulcerans Lesions in Australian Patients. Clinical Infectious Diseases. 70(9). 1993–1997. 6 indexed citations
6.
Cheng, Allen, et al.. (2019). Lessons Learned From a Randomized Controlled Trial of Short-Course Intravenous Antibiotic Therapy for Erysipelas and Cellulitis of the Lower Limb (Switch Trial). Open Forum Infectious Diseases. 6(9). ofz335–ofz335. 7 indexed citations
7.
O’Brien, D., N. Deborah Friedman, Anthony McDonald, et al.. (2018). Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease. PLoS neglected tropical diseases. 12(3). e0006357–e0006357. 23 indexed citations
8.
Friedman, N. Deborah, Yehuda Carmeli, Aaron Walton, & Mitchell J. Schwaber. (2017). Carbapenem-ResistantEnterobacteriaceae: A Strategic Roadmap for Infection Control. Infection Control and Hospital Epidemiology. 38(5). 580–594. 74 indexed citations
9.
Athan, Eugene, et al.. (2017). Increased Severity and Spread ofMycobacterium ulcerans, Southeastern Australia. Emerging infectious diseases. 24(1). 58–64. 41 indexed citations
10.
O’Brien, D., et al.. (2017). Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients. Internal Medicine Journal. 47(9). 1011–1019. 16 indexed citations
11.
Friedman, N. Deborah, Eugene Athan, Aaron Walton, & D. O’Brien. (2016). Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort. Antimicrobial Agents and Chemotherapy. 60(5). 2692–2695. 24 indexed citations
12.
Walton, Aaron, et al.. (2015). Cleaning, resistant bacteria, and antibiotic prescribing in residential aged care facilities. American Journal of Infection Control. 44(3). e19–e21. 5 indexed citations
13.
O’Brien, D., Aaron Walton, Andrew Hughes, et al.. (2013). Risk factors for recurrent Mycobacterium ulcerans disease after exclusive surgical treatment in an Australian cohort. The Medical Journal of Australia. 198(8). 436–439. 19 indexed citations
14.
O’Brien, D., N. Deborah Friedman, Aaron Walton, et al.. (2013). Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulceransinfections. BMC Infectious Diseases. 13(1). 416–416. 47 indexed citations
15.
16.
O’Brien, D., Anthony McDonald, Peter Callan, et al.. (2012). Successful Outcomes with Oral Fluoroquinolones Combined with Rifampicin in the Treatment of Mycobacterium ulcerans: An Observational Cohort Study. PLoS neglected tropical diseases. 6(1). e1473–e1473. 46 indexed citations
17.
Athan, Eugene, N. Deborah Friedman, Andrew Hughes, et al.. (2012). Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population. The Medical Journal of Australia. 196(5). 341–344. 57 indexed citations
18.
Walton, Aaron, Benjamin P. Howden, Lindsay Grayson, & Tony M. Korman. (2007). Continuous-infusion penicillin home-based therapy for serious infections due to penicillin-susceptible pathogens. International Journal of Antimicrobial Agents. 29(5). 544–548. 10 indexed citations
19.
Friedman, N. Deborah, Keith S. Kaye, Jason E. Stout, et al.. (2002). Friedman ND, Kaye KS, Stout J, et al. Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşe Yüce Breakdown of academic impact, for papers by Nicolynn C. Cole Breakdown of academic impact, for papers by Sittana S. Elshafie Breakdown of academic impact, for papers by Sydney Malama Breakdown of academic impact, for papers by Anupop Jitmuang Breakdown of academic impact, for papers by Claudio Castelberg Breakdown of academic impact, for papers by P. Gialanella Breakdown of academic impact, for papers by Raman Sardana Breakdown of academic impact, for papers by Kaye Evans Breakdown of academic impact, for papers by Pilar Marín‐Casanova
Rankless by CCL
2026